ADMIRE-ICD (Completed)
AdreView™ Myocardial Imaging for Risk Evaluation – A multicentre trial to guide ICD implantation in NYHA class II & III heart failure patients with 30%≤LVEF≤35%
- Medicine
- Jodium-123 meta-iodobenzylguanidine (MIBG)
- Population
- Heart failure
- Phase
- III
- Starting year
- 2016
- More information
- ClinivalTrials.gov